156 related articles for article (PubMed ID: 16997055)
1. An interventional controlled trial comparing 2 management models for the treatment of tunneled cuffed catheter bacteremia: a collaborative team model versus usual physician-managed care.
Mokrzycki MH; Zhang M; Golestaneh L; Laut J; Rosenberg SO
Am J Kidney Dis; 2006 Oct; 48(4):587-95. PubMed ID: 16997055
[TBL] [Abstract][Full Text] [Related]
2. Tunnelled haemodialysis catheter bacteraemia: risk factors for bacteraemia recurrence, infectious complications and mortality.
Mokrzycki MH; Zhang M; Cohen H; Golestaneh L; Laut JM; Rosenberg SO
Nephrol Dial Transplant; 2006 Apr; 21(4):1024-31. PubMed ID: 16449293
[TBL] [Abstract][Full Text] [Related]
3. Favourable outcomes in episodes of Pseudomonas bacteraemia when associated with tunnelled cuffed catheters (TCCs) in chronic haemodialysis patients.
Golestaneh L; Laut J; Rosenberg S; Zhang M; Mokrzycki MH
Nephrol Dial Transplant; 2006 May; 21(5):1328-33. PubMed ID: 16421157
[TBL] [Abstract][Full Text] [Related]
4. Bacteremia associated with tunneled, cuffed hemodialysis catheters.
Saad TF
Am J Kidney Dis; 1999 Dec; 34(6):1114-24. PubMed ID: 10585322
[TBL] [Abstract][Full Text] [Related]
5. Aspirin treatment is associated with a significantly decreased risk of Staphylococcus aureus bacteremia in hemodialysis patients with tunneled catheters.
Sedlacek M; Gemery JM; Cheung AL; Bayer AS; Remillard BD
Am J Kidney Dis; 2007 Mar; 49(3):401-8. PubMed ID: 17336701
[TBL] [Abstract][Full Text] [Related]
6. A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis.
Solomon LR; Cheesbrough JS; Ebah L; Al-Sayed T; Heap M; Millband N; Waterhouse D; Mitra S; Curry A; Saxena R; Bhat R; Schulz M; Diggle P
Am J Kidney Dis; 2010 Jun; 55(6):1060-8. PubMed ID: 20207458
[TBL] [Abstract][Full Text] [Related]
7. Prospective follow-up of a novel design haemodialysis catheter; lower infection rates and improved survival.
Weijmer MC; Vervloet MG; ter Wee PM
Nephrol Dial Transplant; 2008 Mar; 23(3):977-83. PubMed ID: 17984107
[TBL] [Abstract][Full Text] [Related]
8. Tunneled catheter-antibiotic lock therapy for prevention of dialysis catheter-related infections: a single center experience.
Al-Hwiesh AK
Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):593-602. PubMed ID: 18580019
[TBL] [Abstract][Full Text] [Related]
9. Comparison of low-dose gentamicin with minocycline as catheter lock solutions in the prevention of catheter-related bacteremia.
Nori US; Manoharan A; Yee J; Besarab A
Am J Kidney Dis; 2006 Oct; 48(4):596-605. PubMed ID: 16997056
[TBL] [Abstract][Full Text] [Related]
10. Successful prevention of tunneled, central catheter infection by antibiotic lock therapy using vancomycin and gentamycin.
Al-Hwiesh AK; Abdul-Rahman IS
Saudi J Kidney Dis Transpl; 2007 Jun; 18(2):239-47. PubMed ID: 17496402
[TBL] [Abstract][Full Text] [Related]
11. Analysis of risk factors for catheter-related bacteremia in 2000 permanent dual catheters for hemodialysis.
Lemaire X; Morena M; Leray-Moragués H; Henriet-Viprey D; Chenine L; Defez-Fougeron C; Canaud B
Blood Purif; 2009; 28(1):21-8. PubMed ID: 19325236
[TBL] [Abstract][Full Text] [Related]
12. Randomized, controlled trial of topical exit-site application of honey (Medihoney) versus mupirocin for the prevention of catheter-associated infections in hemodialysis patients.
Johnson DW; van Eps C; Mudge DW; Wiggins KJ; Armstrong K; Hawley CM; Campbell SB; Isbel NM; Nimmo GR; Gibbs H
J Am Soc Nephrol; 2005 May; 16(5):1456-62. PubMed ID: 15788475
[TBL] [Abstract][Full Text] [Related]
13. Contamination of transvenous pacemaker leads due to tunneled hemodialysis catheter infection: a report of 2 cases.
Carrillo RG; Garisto JD; Salman L; Merrill D; Asif A
Am J Kidney Dis; 2010 Jun; 55(6):1097-101. PubMed ID: 20363542
[TBL] [Abstract][Full Text] [Related]
14. Enhancing multiyear guideline concordance for bipolar disorder through collaborative care.
Bauer MS; Biswas K; Kilbourne AM
Am J Psychiatry; 2009 Nov; 166(11):1244-50. PubMed ID: 19797436
[TBL] [Abstract][Full Text] [Related]
15. Enhancing the survival of tunneled haemodialysis catheters using an antibiotic lock in the elderly: a randomised, double-blind clinical trial.
Saxena AK; Panhotra BR; Sundaram DS; Morsy MN; Al-Ghamdi AM
Nephrology (Carlton); 2006 Aug; 11(4):299-305. PubMed ID: 16889569
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of the Hemodialysis Infection Prevention with Polysporin Ointment (HIPPO) Study: a quality improvement report.
Battistella M; Bhola C; Lok CE
Am J Kidney Dis; 2011 Mar; 57(3):432-41. PubMed ID: 21216512
[TBL] [Abstract][Full Text] [Related]
17. Surveillance cultures of tunneled cuffed catheter exit sites in chronic hemodialysis patients are of no benefit.
Rosenbaum D; MacRae JM; Djurdjev O; Levin A; Werb R; Kiaii M
Hemodial Int; 2006 Oct; 10(4):365-70. PubMed ID: 17014513
[TBL] [Abstract][Full Text] [Related]
18. Outcome of central venous catheter-related bacteraemia according to compliance with guidelines: experience with 91 episodes.
Wintenberger C; Epaulard O; Hincky-Vitrat V; Brion JP; Recule C; François P; Stahl JP; Pavese P
J Hosp Infect; 2012 Mar; 80(3):245-51. PubMed ID: 22230103
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic lock for treatment of tunneled hemodialysis catheter bacteremia.
Maya ID
Semin Dial; 2008; 21(6):539-41. PubMed ID: 19000121
[TBL] [Abstract][Full Text] [Related]
20. Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia.
Jenkins TC; Price CS; Sabel AL; Mehler PS; Burman WJ
Clin Infect Dis; 2008 Apr; 46(7):1000-8. PubMed ID: 18444816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
